PortfoliosLab logo

TransCode Therapeutics, Inc. (RNAZ)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$2.01
  • EMA (50)$2.52
  • EMA (200)$2.73
  • Average Volume$17.60K
  • Market Capitalization$27.12M

RNAZShare Price Chart


Chart placeholderClick Calculate to get results

RNAZPerformance

The chart shows the growth of $10,000 invested in TransCode Therapeutics, Inc. on Jul 8, 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,025 for a total return of roughly -49.75%. All prices are adjusted for splits and dividends.


RNAZ (TransCode Therapeutics, Inc.)
Benchmark (^GSPC)

RNAZReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-28.98%-12.57%
YTD-20.87%-18.14%
6M-25.56%-17.07%
1Y-49.75%-10.48%
5YN/AN/A
10YN/AN/A

RNAZMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

RNAZSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.


Chart placeholderNot enough data

RNAZDividend History


TransCode Therapeutics, Inc. doesn't pay dividends

RNAZDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


RNAZ (TransCode Therapeutics, Inc.)
Benchmark (^GSPC)

RNAZWorst Drawdowns

The table below shows the maximum drawdowns of the TransCode Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the TransCode Therapeutics, Inc. is 68.84%, recorded on May 20, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.84%Jul 13, 2021218May 20, 2022

RNAZVolatility Chart

Current TransCode Therapeutics, Inc. volatility is 64.72%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


RNAZ (TransCode Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with TransCode Therapeutics, Inc.


Loading data...

More Tools for TransCode Therapeutics, Inc.